About Us
Research Watch
•स्क्रिनमा देखिने चुरोट: सुर्तीजन्य हानि न्यूनीकरण नीतिमा दक्षिण एसियाले अझै के छुटाइरहेको छ•नेपालमा पिसाब नलीको संक्रमण र एन्टिबायोटिक प्रतिरोधको बढ्दो संकट•Frontline Perspectives on Nursing Leadership in Nepal•Protecting the Smallest Lungs from the Hidden Grip of RSV in Kathmandu•The Heavy Burden of Bullying on Student Wellbeing in Nepal•The Emerging Landscape of Thyroid Health in Central Nepal•How a Recent Western Nepal Study is Redefining Anemia Diagnosis•How H. Pylori is Impacting the Health of Karnali’s High-Altitude Communities•Sweet Poison, Bitter Reality: The Unseen Diabetes Epidemic Among Nepal’s Youth•How Missing Checklists and Protocols are Costing Lives in Nepal’s ERs•स्क्रिनमा देखिने चुरोट: सुर्तीजन्य हानि न्यूनीकरण नीतिमा दक्षिण एसियाले अझै के छुटाइरहेको छ•नेपालमा पिसाब नलीको संक्रमण र एन्टिबायोटिक प्रतिरोधको बढ्दो संकट•Frontline Perspectives on Nursing Leadership in Nepal•Protecting the Smallest Lungs from the Hidden Grip of RSV in Kathmandu•The Heavy Burden of Bullying on Student Wellbeing in Nepal•The Emerging Landscape of Thyroid Health in Central Nepal•How a Recent Western Nepal Study is Redefining Anemia Diagnosis•How H. Pylori is Impacting the Health of Karnali’s High-Altitude Communities•Sweet Poison, Bitter Reality: The Unseen Diabetes Epidemic Among Nepal’s Youth•How Missing Checklists and Protocols are Costing Lives in Nepal’s ERs

Task Force 4: Clinical Considerations for the Care of Athletes with Genetic Cardiomyopathies.

Researchers

Sabiha Gati, Michael J Ackerman, Aaron L Baggish, Jonathan H Kim, Benjamin D Levine, Martin Maron, Matthew Martinez, Sharlene M Day

Abstract

The updated AHA/ACC Scientific Statement on Clinical Considerations for Competitive Sports Participation for Athletes with Cardiovascular Conditions presents the clinical considerations for athletes with genetic cardiomyopathies, including hypertrophic, dilated, arrhythmogenic, and left ventricular hypertrabeculation. This ACSM Official Pronouncement complements the 2020 ACC/AHA Scientific Statement by providing athlete-specific context, practical guidance for shared decision-making, and genotype-informed risk assessment for competitive sports participation, moving away from blanket sports disqualifications. Sports participation recommendations for each condition are tailored to risk levels, symptomatology, and genotype. Regular follow-ups and close surveillance are advised. This evolving approach underscores the importance of individualized care, ongoing research, and the integration of new data to better inform shared decision-making on the risks and benefits of competitive sports in athletes with cardiomyopathies.
Source: PubMed (PMID: 43024813)View Original on PubMed